Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.
International journal of molecular sciences
View this publicationInternational journal of molecular sciences
View this publicationCancer treatment reviews
View this publicationExpert review of hematology
View this publicationCell death & disease
View this publicationFrontiers in immunology
View this publicationFrontiers in oncology
View this publicationExperimental hematology
View this publicationCancers
View this publicationRheumatology international
View this publicationBlood cancer journal
View this publication